Suppr超能文献

电离辐射增强 dl922-947 介导的间变性甲状腺癌细胞死亡。

Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells.

机构信息

Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia, Università di Napoli Federico II, Italy.

出版信息

Endocr Relat Cancer. 2013 Aug 19;20(5):633-47. doi: 10.1530/ERC-13-0001. Print 2013 Oct.

Abstract

dl922-947 is an oncolytic adenovirus potentially suitable for the treatment of aggressive localized tumors, such as anaplastic thyroid carcinoma (ATC). In this study, we have analyzed the effects of dl922-947 in combination with ionizing radiations, testing different schedules of administration and observing synergistic effects only when ATC cells were irradiated 24 h prior to viral infection. Cells undergoing combined treatment exhibited a marked increase in cell death and viral replication, suggesting that irradiation blocks cells in a more permissive state for viral life cycle. We also show that dl922-947 triggers a DNA damage response, characterized by mobilization of the MRN complex (composed by Mre11-Rad50-Nbs1), accumulation of γH2AX, and activation of the checkpoint kinases ataxia telangiectasia mutated (ATM) and Chk1. Based on these observations, we speculate that the DNA damage response acts as a cellular protective mechanism to hinder viral infection and replication. To confirm this hypothesis, we demonstrate that the ATM inhibitor KU55933 increased the oncolytic activity of dl922-947 and its replication. Finally, we validate the potential therapeutic use of this approach by showing in vivo that the combined treatment slows tumor xenograft growth more potently than either irradiation or infection alone.

摘要

dl922-947 是一种溶瘤腺病毒,可能适用于治疗侵袭性局部肿瘤,如间变性甲状腺癌(ATC)。在这项研究中,我们分析了 dl922-947 与电离辐射联合使用的效果,测试了不同的给药方案,仅当 ATC 细胞在病毒感染前 24 小时接受照射时才观察到协同作用。联合治疗的细胞表现出明显的细胞死亡和病毒复制增加,表明照射会使细胞处于更有利于病毒生命周期的状态。我们还表明,dl922-947 触发 DNA 损伤反应,其特征是 MRN 复合物(由 Mre11-Rad50-Nbs1 组成)的动员、γH2AX 的积累以及共济失调毛细血管扩张突变(ATM)和 Chk1 检查点激酶的激活。基于这些观察结果,我们推测 DNA 损伤反应作为一种细胞保护机制,阻碍病毒感染和复制。为了证实这一假设,我们证明 ATM 抑制剂 KU55933 增加了 dl922-947 的溶瘤活性及其复制。最后,我们通过显示联合治疗比单独照射或感染更有效地减缓肿瘤异种移植物生长,验证了这种方法的潜在治疗用途。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验